EdgeMarketInstruments › PRPH

PRPH — ProPhase Labs, Inc.

US Healthcare Pharma & biotech equity mkt cap 5.7M
0.36 +0.00% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 0.36 · high 6.08

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+0.00%
1 week+0.00%
1 month+0.00%
3 months+0.00%
6 months+0.00%
Year to date+0.00%
1 year-89.01%
3 years-99.35%
5 years-99.44%

Technicals

RSI 14100.0
vs 50-day avg+0.00%
vs 200-day avg-42.25%
Volatility 1y89.3%
Max drawdown 1y-94.03%
Daily bars held2,674
History from2016-01-04

Largest institutional holders

managervalueshares
CoreCap Advisors, LLC110
Farther Finance Advisors, LLC110

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-192026-06-30on EDGAR ↗
NT 10-Q2026-08-142026-06-30on EDGAR ↗
8-K2026-08-062026-07-31on EDGAR ↗
10-Q/A2026-07-092026-03-31on EDGAR ↗
10-Q/A2026-07-072026-03-31on EDGAR ↗
10-Q2026-06-302026-03-31on EDGAR ↗
10-K2026-06-012025-12-31on EDGAR ↗
NT 10-Q2026-05-152026-03-31on EDGAR ↗

Recent headlines

Ask the AI about PRPH

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open PRPH in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →